Sandosh Padmanabhan

34.0k total citations · 3 hit papers
183 papers, 5.9k citations indexed

About

Sandosh Padmanabhan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Sandosh Padmanabhan has authored 183 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 50 papers in Endocrinology, Diabetes and Metabolism and 48 papers in Genetics. Recurrent topics in Sandosh Padmanabhan's work include Hormonal Regulation and Hypertension (39 papers), Blood Pressure and Hypertension Studies (38 papers) and Genetic Associations and Epidemiology (36 papers). Sandosh Padmanabhan is often cited by papers focused on Hormonal Regulation and Hypertension (39 papers), Blood Pressure and Hypertension Studies (38 papers) and Genetic Associations and Epidemiology (36 papers). Sandosh Padmanabhan collaborates with scholars based in United Kingdom, United States and Australia. Sandosh Padmanabhan's co-authors include Anna F. Dominiczak, Gordon T. McInnes, Ian Ford, Linsay McCallum, Mark J. Caulfield, Morris J. Brown, David J. Porteous, Thomas M. MacDonald, Isla S. Mackenzie and S. V. Morant and has published in prestigious journals such as The Lancet, Circulation and Physiological Reviews.

In The Last Decade

Sandosh Padmanabhan

171 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

2015 735 citations Thomas M. MacDonald, David R. Webb et al. profile →
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting

2017 349 citations Sandosh Padmanabhan, Naveed Sattar et al. profile →
Cardiac Troponin T and Troponin I in the General Population

2019 211 citations Caroline Hayward, Alex McConnachie et al. profile →

Peers

Countries citing papers authored by Sandosh Padmanabhan

Since Specialization

Citations

This map shows the geographic impact of Sandosh Padmanabhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandosh Padmanabhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandosh Padmanabhan more than expected).

Fields of papers citing papers by Sandosh Padmanabhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandosh Padmanabhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandosh Padmanabhan. The network helps show where Sandosh Padmanabhan may publish in the future.

Co-authorship network of co-authors of Sandosh Padmanabhan

This figure shows the co-authorship network connecting the top 25 collaborators of Sandosh Padmanabhan. A scholar is included among the top collaborators of Sandosh Padmanabhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandosh Padmanabhan. Sandosh Padmanabhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure – LOCHINVAR 2025 ·Journal of Hypertension ·Stefanie Lip, (unknown), (unknown), (unknown), Tomasz J Guzik, Christian Delles, J. Andrew McClure, Linsay McCallum, Rhian M. Touyz, Colin Berry, Sandosh Padmanabhan	0
2	Insights into Uromodulin and Blood Pressure 2024 ·Current Hypertension Reports ·(unknown), Sheon Mary, Christian Delles, Sandosh Padmanabhan, Delyth Graham, Martin McBride, Anna F. Dominiczak	1
3	Beyond Genome-Wide Scans: Advancing Hypertension Genomics Into the Future 2024 ·Hypertension ·Sandosh Padmanabhan, Christian Delles, Anna F. Dominiczak	2
4	Methods applied to neonatal dried blood spot samples for secondary research purposes: a scoping review 2024 ·Critical Reviews in Clinical Laboratory Sciences ·(unknown), Rona J. Strawbridge, Zosia Miedzybrodzka, Riccardo E. Marioni, Mads Melbye, David J. Porteous, Matthew E. Hurles, Naveed Sattar, Cathie Sudlow, Rory Collins, Sandosh Padmanabhan, Jill P. Pell	0
5	Potential Applications of Artificial Intelligence (AI) in Managing Polypharmacy in Saudi Arabia: A Narrative Review 2024 ·Healthcare ·Safaa Alsanosi, Sandosh Padmanabhan	10
6	OPTIMA-BP: empOwering PaTients in MAnaging Blood Pressure – protocol for a randomised parallel group study comparing use of Kvatchii web-based patient education portal as an addition to home blood pressure monitoring 2024 ·Open Heart ·Linsay McCallum, Stefanie Lip, (unknown), (unknown), (unknown), (unknown), Sandosh Padmanabhan	0
7	Long-Term Usage and Improved Clinical Outcomes with Adoption of a COPD Digital Support Service: Key Findings from the RECEIVER Trial 2023 ·International Journal of COPD ·(unknown), (unknown), (unknown), Jacqueline Anderson, (unknown), (unknown), (unknown), Sandosh Padmanabhan, (unknown), (unknown), David J. Lowe, C Carlin	1
8	A Reappraisal of the Effects of L-type Ca2+ Channel Blockers on Store-Operated Ca2+ Entry and Heart Failure 2023 ·Function ·Gary S. Bird, Diane D’Agostin, Safaa Alsanosi, Stefanie Lip, Sandosh Padmanabhan, Anant B. Parekh	2
9	Role of Uromodulin in Salt-Sensitive Hypertension 2022 ·Hypertension ·Sheon Mary, (unknown), Sandosh Padmanabhan, Martin McBride, Delyth Graham, Christian Delles, Anna F. Dominiczak	18
10	Vascular dysfunction and increased cardiovascular risk in hypospadias 2022 ·European Heart Journal ·Angela Lucas-Herald, (unknown), Rhéure Alves-Lopes, (unknown), (unknown), Stuart O’Toole, (unknown), (unknown), (unknown), (unknown), Katriona Brooksbank, Linsay McCallum, Christian Delles, Sandosh Padmanabhan, (unknown), Rhian M. Touyz	3
11	Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD) 2020 ·American Journal of Hypertension ·Linsay McCallum, Katriona Brooksbank, Alex McConnachie, Alisha Aman, Stefanie Lip, Jesse Dawson, I. MacIntyre, Thomas M. MacDonald, David R. Webb, Sandosh Padmanabhan	11
12	Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study 2017 ·PLoS ONE ·Oliver van Hecke, Lynne J. Hocking, Nicola Torrance, Archie Campbell, Sandosh Padmanabhan, David J. Porteous, Andrew M. McIntosh, Andrea Burri, (unknown), Frances M. K. Williams, Blair H. Smith	113
13	Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766) 2017 ·Translational Psychiatry ·Eleanor M. Wigmore, Toni‐Kim Clarke, David M. Howard, Mark J. Adams, Lynsey S. Hall, Yanni Zeng, Jude Gibson, Gail Davies, Ana Maria Fernandez-Pujals, Pippa A. Thomson, Caroline Hayward, Blair H. Smith, Lynne J. Hocking, Sandosh Padmanabhan, Ian J. Deary, David J. Porteous, Kristin K. Nicodemus, Andrew M. McIntosh	17
14	Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12 , A1BG , and the Selectin Region and Cardiovascular Outcomes 2013 ·Hypertension ·Caitrin W. McDonough, Yan Gong, Sandosh Padmanabhan, Ben Burkley, Taimour Langaee, Olle Melander, Carl J. Pepine, Anna F. Dominiczak, Rhonda M. Cooper‐DeHoff, Julie A. Johnson	27
15	Familial and Phenotypic Associations of the Aldosterone Renin Ratio 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Samantha Alvarez‐Madrazo, Sandosh Padmanabhan, Bongani M. Mayosi, Hugh Watkins, Peter Avery, A. Michael Wallace, Robert Fraser, Eleanor Davies, Bernard Keavney, John Connell	32
16	Discovering the genetic determinants of complex diseases 2009 ·Current Science ·Sandosh Padmanabhan, Cristina Menni, Dorairaj Prabhakaran, Anna F. Dominiczak	1
17	Association between variants of the human GSTM gene family and hypertension 2006 ·Hypertension ·Christian Delles, (unknown), Patricia B. Munroe, Sandosh Padmanabhan, (unknown), Nick J.R. Brain, Morris J. Brown, Nilesh J. Samani, D Clayton, Martin Farrall, John Webster, J. M. C. Connell, Mark J. Caulfield, Anna F. Dominiczak	1
18	Chromosome 2p shows genome wide significant linkage to of anti-hypertensive medication response in the British genetics of hypertension (BRIGHT) study. 2005 ·Hypertension ·Sandosh Padmanabhan, Chris Wallace, Patricia B. Munroe, M. J. Brown, N. J. Samani, D Clayton, Martin Farrall, Jennifer Webster, M Lathrop, Mark J. Caulfield, Anna F. Dominiczak, J. M. C. Connell	3
19	Variation at the beta-1 adrenoceptor gene locus affects left ventricular mass in renal failure. 2002 ·ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) ·Tony Stanton, Gordon C. Inglis, Sandosh Padmanabhan, Anna F. Dominiczak, Alan G. Jardine, John Connell	15
20	Independent Y chromosome markers associated with blood pressure and testosterone levels 2002 ·Fadi J. Charchar, Maciej Tomaszewski, Sandosh Padmanabhan, B Łacka, Nathan Anderson, E Zukowska-Szczechowska, W Grzeszczak, Anna F. Dominiczak	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact